Millions in funding and new board members for Belgian mRNA company
The mRNA technologies company eTheRNA has raised €39 million ($38.7 million) in series B2 financing.…
The mRNA technologies company eTheRNA has raised €39 million ($38.7 million) in series B2 financing.…
Vaccines for COVID-19 have saved lives all over the world, but their protection is threatened…
Attempts to increase global Covid-19 vaccine coverage with a temporary patent waiver have been met…
Belgian biotech eTheRNA has secured €34M in Series B funding to progress to the clinic…
The first vaccine against coronavirus disease could one day be made of mRNA. How is…
With a massive €530M ($604M) raised, US-based Moderna has made a record biotech IPO. The…
eTheRNA has started a Phase Ib trial in patients with melanoma to test a cancer immunotherapy…
The young field of mRNA therapeutics is booming and generating huge expectations. Which are the main players…